Spots Global Cancer Trial Database for Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Official Title: Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Study ID: NCT01104181
Interventions
Study Description
Brief Summary: This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Laser Surgery Care, Inc., New York, New York, United States
Contact Details
Name: Stephen E Goldstone, MD
Affiliation: Mount Sinai Medical School
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
